Publication
Germany’s biotech sector is based on a unique innovation ecosystem where scientists, start-ups, small and medium-sized enterprises (SMEs) and large businesses cooperate intensively to develop innovations. The various actors share their knowledge and drive forward new solutions that are urgently needed to achieve key political goals – ranging from protecting the climate and preserving biodiversity to securing global healthcare and food supply. This open innovation ecosystem relies on research actors being able to patent their innovations.
- Publication
- 4 Pages / DIN A4
- Target group
- Breite Öffentlichkeit
Biopatents
Contents
- Biopatents: Maintaining the basis of Germany’s innovation ecosystem
- Patent protection and plants: Breeders’ interests are safeguarded
- The example of Ogura highlights: Patents offer massive added value
Contact
For questions or suggestions, please feel free to contact us.
